市場調査レポート

商品コード

1568352

疼痛管理デバイス市場：2035年までの業界動向と世界の予測 - デバイスタイプ別、神経刺激デバイスタイプ別、応用分野別、購入形態別、エンドユーザー別、地域別

Pain Management Devices Market, Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Device, Type of Neurostimulation Device, Application Area, Mode of Purchase, End User and Geographical Regions

出版日: 2024年07月01日
発行: Roots Analysis
ページ情報: 英文 220 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,799 688,992円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (One-Location Site License)

USD 6,999 1,004,846円

レポートPDFを同一所在地における特定事業ユニットに属する全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Department License)

USD 10,599 1,521,698円

レポートPDFを部署単位で12名様までご利用いただけるライセンスです。同一部署内であれば、地理的に同じ地点に存在する必要はありません。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 17,999 2,584,116円

レポートPDFを同社の国内外拠点における全ての方にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

疼痛管理デバイスの市場規模は、2024年に79億4,000万米ドルになるとみられ、2035年までの予測期間中にCAGR 4.8％で成長すると予測されています。

疼痛は不快な感覚体験を伴う複雑な現象であり、主に急性または慢性の身体的損傷に関連し、様々な心理的、生物学的、社会的要因によって悪化します。疼痛の蔓延は相当なもので、世界的に相当数の個人に影響を及ぼしています。例えば、欧州では、フランスとドイツの人口を合わせた約1億5,000万人が慢性疼痛に悩まされており、年間3,000億ユーロ以上の経済的負担につながっています。様々な地域で疼痛が広く蔓延していることから、患者の転帰を改善し、生活の質を高めるためには、効果的な疼痛管理ソリューションが不可欠です。

疼痛管理には一般的に、筋骨格痛、脊髄痛、神経障害性疼痛を持つ患者の苦痛を和らげるために、疼痛管理デバイスや治療法が使用されます。オピオイド、非ステロイド性抗炎症薬、抗うつ薬、抗てんかん薬などの薬理学的介入は、急性および慢性の疼痛を管理・治療するための第一選択薬として機能します。オピオイドは、薬効発現が早く、即座に疼痛緩和をもたらすことから、中等度から重度の疼痛管理に最も広く使用されている鎮痛薬のひとつと考えられています。しかし、これらの薬剤は、日常活動を妨げ、心拍数を低下させ、薬物中毒や死につながる可能性のある陶酔状態を誘発するなど、重大な副作用を伴います。2019年には、世界中で約60万人の死者が薬物の過剰摂取に起因しており、これらの死者の80％近くがオピオイドの過剰使用に関連していることに留意することが重要です。

オピオイド危機は、業界利害関係者に、疼痛を効果的に管理するための神経刺激装置、輸液ポンプ、高周波アブレーション装置など、患者中心の膨大な疼痛管理デバイスの開発を促しました。これらの機器は、疼痛を軽減するための第二選択の治療法として役立っています。これらのデバイスには、薬物相互作用が最小限または皆無であること、標的治療が可能であること、薬物への依存度が低いこと、副作用が最小限であることなど、さまざまな利点があります。さらに、これらの機器は個々のニーズに合わせて強さや治療時間を調整できるため、患者の快適性が向上します。患者中心の機器を開発するために利害関係者が研究開発を続けていることから、世界の疼痛管理デバイス市場は予測期間中に健全なCAGRで成長すると予想されます。

当レポートでは、世界の疼痛管理デバイス市場について調査し、市場の概要とともに、デバイスタイプ別、神経刺激デバイスタイプ別、応用分野別、購入形態別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 6.1 Leading Pain Management Device Developers: Information on Year of Establishment, Company Size, Location of Headquarters and Devices
Table 6.2 Leading Pain Management Device Developers: Information on Type of Pain Management Device
Table 6.3 Leading Pain Management Device Developers: Information on Type of Treatment and Type of Pain Managed
Table 6.4 Leading Pain Management Device Developers: Information on Application Area
Table 8.1 Leading Pain Management Device Developers: List of Companies Profiled
Table 8.2 Abbott: Company Overview
Table 8.3 Abbott: Pain Management Devices Portfolio
Table 8.4 Abbott: Recent Developments and Future Outlook
Table 8.5 Avanos Medical: Company Overview
Table 8.6 Avanos Medical: Pain Management Devices Portfolio
Table 8.7 Avanos Medical: Recent Developments and Future Outlook
Table 8.8 Becton, Dickinson and Company: Company Overview
Table 8.9 Becton, Dickinson and Company (BD): Pain Management Devices Portfolio
Table 8.10 Becton, Dickinson and Company (BD): Recent Developments and Future Outlook
Table 8.11 Medtronic: Company Overview
Table 8.12 Medtronic: Pain Management Devices Portfolio
Table 8.13 Medtronic: Recent Developments and Future Outlook
Table 8.14 Nalu Medical: Company Overview
Table 8.15 Nalu Medical: Pain Management Device Portfolio
Table 8.16 Nalu Medical: Recent Developments and Future Outlook
Table 8.17 Nevro: Company Overview
Table 8.18 Nevro: Pain Management Devices Portfolio
Table 8.19 Nevro: Recent Developments and Future Outlook
Table 8.20 ZetrOZ Systems: Company Overview
Table 8.21 ZetrOZ Systems: Pain Management Devices Portfolio
Table 8.22 ZetrOZ Systems: Recent Developments and Future Outlook
Table 8.23 Zynex Medical: Company Overview
Table 8.24 Zynex Medical: Pain Management Devices Portfolio
Table 8.25 Zynex Medical: Recent Developments and Future Outlook
Table 8.26 AppliedVR: Company Overview
Table 8.27 AppliedVR: Pain Management Device Portfolio
Table 8.28 AtriCure: Company Overview
Table 8.29 AtriCure: Pain Management Device Portfolio
Table 8.30 BioElectronics: Company Overview
Table 8.31 BioElectronics: Pain Management Devices Portfolio
Table 8.32 Hexainnoheal: Company Overview
Table 8.33 Hexainnoheal: Pain Management Device Portfolio
Table 8.34 Litemed: Company Overview
Table 8.35 Litemed: Pain Management Device Portfolio
Table 8.36 Micrel Medical Devices: Company Overview
Table 8.37 Micrel Medical Devices: Pain Management Devices Portfolio
Table 8.38 Smileyscope: Company Overview
Table 8.39 Smileyscope: Pain Management Device Portfolio
Table 8.40 Stryker: Company Overview
Table 8.41 Stryker: Pain Management Device Portfolio
Table 21.1 Leading Pain Management Device Developers: Distribution by Year of Establishment
Table 21.2 Leading Pain Management Device Developers: Distribution by Company Size
Table 21.3 Leading Pain Management Device Developers: Distribution by Location of Headquarters
Table 21.4 Leading Pain Management Device Developers: Distribution by Company Size and Location of Headquarters
Table 21.5 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device
Table 21.6 Leading Pain Management Device Developers: Distribution by Type of Neurostimulation Device
Table 21.7 Leading Pain Management Device Developers: Distribution by Type of Ablation Device
Table 21.8 Leading Pain Management Device Developers: Distribution by Type of Analgesic Infusion Pump
Table 21.9 Leading Pain Management Device Developers: Distribution by Type of Treatment
Table 21.10 Leading Pain Management Device Developers: Distribution by Type of Pain Managed
Table 21.11 Leading Pain Management Device Developers: Distribution by Application Area
Table 21.12 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device and Application Area
Table 21.13 Publication Analysis: Cumulative Year-Wise Trend, since 2019
Table 21.14 Publication Analysis: Distribution by Type of Publication
Table 21.15 Publication Analysis: Distribution by Copyright Holders
Table 21.16 Most Active Publishers: Distribution by Number of Publications
Table 21.17 Key Journals: Distribution by Number of Publications
Table 21.18 Key Journals: Distribution by Impact Factor
Table 21.19 Global Pain Management Devices Market, till 2035: Base Scenario (USD Billion)
Table 21.20 Global Pain Management Devices Market, till 2035: Conservative Scenario (USD Billion)
Table 21.21 Global Pain Management Devices Market, till 2035: Optimistic Scenario (USD Billion)
Table 21.22 Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
Table 21.23 Pain Management Devices Market for Neurostimulation Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.24 Pain Management Devices Market for Infusion Pumps, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.25 Pain Management Devices Market for Ablation Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.26 Pain Management Devices Market for Virtual Reality Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.27 Pain Management Devices Market for Other Pain Management Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.28 Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
Table 21.29 Pain Management Devices Market for Spinal Cord Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.30 Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.31 Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.32 Pain Management Devices Market for Deep Brain Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.33 Pain Management Devices Market for Other Stimulators, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.34 Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
Table 21.35 Pain Management Devices Market for Neuropathic Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.36 Pain Management Devices Market for Musculoskeletal Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.37 Pain Management Devices Market for Cancer Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.38 Pain Management Devices Market for Trauma and Surgical Pain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.39 Pain Management Devices Market for Facial Pain and Migraine, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.40 Pain Management Devices Market for Other Application Areas, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.41 Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
Table 21.42 Pain Management Devices Market for Prescription, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.43 Pain Management Devices Market for Over-the-Counter, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.44 Pain Management Devices Market: Distribution by End Users, 2024 and 2035
Table 21.45 Pain Management Devices Market for Hospitals and Clinics, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.46 Pain Management Devices Market for Physiotherapy Centers, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.47 Pain Management Devices Market for Other End Users, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.48 Pain Management Devices Market: Distribution by Key Geographical Regions, 2024 and 2035
Table 21.49 Pain Management Devices Market in North America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.50 Pain Management Devices Market in the US, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.51 Pain Management Devices Market in Canada, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.52 Pain Management Devices Market in Europe, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.53 Pain Management Devices Market in Germany, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.54 Pain Management Devices Market in France, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.55 Pain Management Devices Market in the UK, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.56 Pain Management Devices Market in Spain, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.57 Pain Management Devices Market in Italy, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.58 Pain Management Devices Market in Rest of Europe, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.59 Pain Management Devices Market in Asia-Pacific, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.60 Pain Management Devices Market in China, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.61 Pain Management Devices Market in Japan, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.62 Pain Management Devices Market in Australia, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.63 Pain Management Devices Market in India, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.64 Pain Management Devices Market in South Korea, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.65 Pain Management Devices Market in Rest of Asia-Pacific, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.66 Pain Management Devices Market in Middle East and North Africa, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.67 Pain Management Devices Market in Israel, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.68 Pain Management Devices Market in Saudi Arabia, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.69 Pain Management Devices Market in UAE, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.70 Pain Management Devices Market in Latin America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.71 Pain Management Devices Market in Brazil, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.72 Pain Management Devices Market in Mexico, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 21.73 Pain Management Devices Market in Rest of Latin America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)

List of Figures

Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Secondary Research: Data Sources
Figure 3.1 Lessons Learnt from Past Recessions
Figure 4.1 Executive Summary: Pain Management Device Developers: Market Landscape of Leading Players
Figure 4.2 Executive Summary: Publication Analysis
Figure 4.3 Executive Summary: Pain Management Devices: Market Forecast and Opportunity Analysis
Figure 5.1 Classification of Pain
Figure 5.2 Types of Pain Management Therapeutics
Figure 6.1 Leading Pain Management Device Developers: Distribution by Year of Establishment
Figure 6.2 Leading Pain Management Device Developers: Distribution by Company Size
Figure 6.3 Leading Pain Management Device Developers: Distribution by Location of Headquarters
Figure 6.4 Leading Pain Management Device Developers: Distribution by Company Size and Location of Headquarters
Figure 6.5 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device
Figure 6.6 Leading Pain Management Device Developers: Distribution by Type of Neurostimulation Device
Figure 6.7 Leading Pain Management Device Developers: Distribution by Type of Ablation Device
Figure 6.8 Leading Pain Management Device Developers: Distribution by Type of Analgesic Infusion Pump
Figure 6.9 Leading Pain Management Device Developers: Distribution by Type of Treatment
Figure 6.10 Leading Pain Management Device Developers: Distribution by Type of Pain Managed
Figure 6.11 Leading Pain Management Device Developers: Distribution by Application Area
Figure 6.12 Leading Pain Management Device Developers: Distribution by Type of Pain Management Device and Application Area
Figure 7.1 Leading Pain Management Device Developers: 3-D Bubble Chart
Figure 7.2 Abbott
Figure 7.3 Medtronic
Figure 7.4 Zynex Medical
Figure 7.5 Boston Scientific
Figure 7.6 OMRON Healthcare
Figure 7.7 Leading Pain Management Device Developers: Benchmarking by Competitiveness
Figure 7.8 Leading Pain Management Device Developers: Benchmarking by Portfolio Strength
Figure 7.9 Leading Pain Management Device Developers: Benchmarking by Application Area
Figure 8.1 Abbott: Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Figure 8.2 Avanos Medical: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 8.3 Becton, Dickinson and Company (BD): Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Figure 8.4 Medtronic: Business Segment-wise Revenues and Consolidated Financial Details (USD Billion)
Figure 8.5 Nalu Medical: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 8.6 Nevro: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 8.7 Zynex Medical: Business Segment-wise Revenues and Consolidated Financial Details (USD Million)
Figure 8.8 Key Winning Strategies of Leading Players
Figure 8.9 Key Winning Strategies of Other Leading Players
Figure 9.1 Publication Analysis: Cumulative Year-Wise Trend, since 2019
Figure 9.2 Publication Analysis: Distribution by Type of Publication
Figure 9.3 Publication Analysis: Distribution by Copyright Holders
Figure 9.4 Word Cloud Analysis: Emerging Focus Areas
Figure 9.5 Most Active Publishers: Distribution by Number of Publications
Figure 9.6 Key Journals: Distribution by Number of Publications
Figure 9.7 Key Journals: Distribution by Impact factor
Figure 10.1 Porter's Five Forces: Harvey Ball Analysis
Figure 10.2 Threats of New Entrants
Figure 10.3 Bargaining Power of Buyers
Figure 10.4 Bargaining Power of Suppliers
Figure 10.5 Threats of Substitute Products
Figure 10.6 Rivalry among Existing Competitors
Figure 10.7 Porter's Five Forces: Concluding Remarks
Figure 11.1 Market Drivers
Figure 11.2 Market Restraints
Figure 11.3 Market Opportunities
Figure 11.4 Market Challenges
Figure 12.1 Global Pain Management Devices Market, till 2035: Base Scenario (USD Billion)
Figure 12.2 Global Pain Management Devices Market, till 2035: Conservative Scenario (USD Billion)
Figure 12.3 Global Pain Management Devices Market, till 2035: Optimistic Scenario (USD Billion)
Figure 13.1 Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
Figure 13.2 Pain Management Devices Market for Neurostimulation Devices, till 2035
Figure 13.3 Pain Management Devices Market for Infusion Pumps, till 2035
Figure 13.4 Pain Management Devices Market for Ablation Devices, till 2035
Figure 13.5 Pain Management Devices Market for Virtual Reality Devices, till 2035
Figure 13.6 Pain Management Devices Market for Other Pain Management Devices, till 2035
Figure 14.1 Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
Figure 14.2 Pain Management Devices Market for Spinal Cord Stimulators, till 2035
Figure 14.3 Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035
Figure 14.4 Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035
Figure 14.5 Pain Management Devices Market for Deep Brain Stimulators, till 2035
Figure 14.6 Pain Management Devices Market for Other Stimulators, till 2035
Figure 15.1 Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
Figure 15.2 Pain Management Devices Market for Neuropathic Pain, till 2035
Figure 15.3 Pain Management Devices Market for Musculoskeletal Pain, till 2035
Figure 15.4 Pain Management Devices Market for Cancer Pain, till 2035
Figure 15.5 Pain Management Devices Market for Trauma and Surgical Pain, till 2035
Figure 15.6 Pain Management Devices Market for Facial Pain and Migraine, till 2035
Figure 15.7 Pain Management Devices Market for Other Application Areas, till 2035
Figure 16.1 Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
Figure 16.2 Pain Management Devices Market for Prescription, till 2035
Figure 16.3 Pain Management Devices Market for Over-the-Counter, till 2035
Figure 17.1 Pain Management Devices Market: Distribution by End Users, 2024 and 2035
Figure 17.2 Pain Management Devices Market for Hospitals and Clinics, till 2035
Figure 17.3 Pain Management Devices Market for Physiotherapy Centers, till 2035
Figure 17.4 Pain Management Devices Market for Other End Users, till 2035
Figure 18.1 Pain Management Devices Market: Distribution by Geographical Regions, 2024 and 2035
Figure 18.2 Pain Management Devices Market in North America, till 2035
Figure 18.3 Pain Management Devices Market in the US, till 2035
Figure 18.4 Pain Management Devices Market in Canada, till 2035
Figure 18.5 Pain Management Devices Market in Europe, till 2035
Figure 18.6 Pain Management Devices Market in Germany, till 2035
Figure 18.7 Pain Management Devices Market in France, till 2035
Figure 18.8 Pain Management Devices Market in the UK, till 2035
Figure 18.9 Pain Management Devices Market in Spain, till 2035
Figure 18.10 Pain Management Devices Market in Italy, till 2035
Figure 18.11 Pain Management Devices Market in Rest of Europe, till 2035
Figure 18.12 Pain Management Devices Market in Asia-Pacific, till 2035
Figure 18.13 Pain Management Devices Market in China, till 2035
Figure 18.14 Pain Management Devices Market in Japan, till 2035
Figure 18.15 Pain Management Devices Market in Australia, till 2035
Figure 18.16 Pain Management Devices Market in India, till 2035
Figure 18.17 Pain Management Devices Market in South Korea, till 2035
Figure 18.18 Pain Management Devices Market in Rest of Asia-Pacific, till 2035
Figure 18.19 Pain Management Devices Market in Middle East and North Africa, till 2035
Figure 18.20 Pain Management Devices Market in Israel, till 2035
Figure 18.21 Pain Management Devices Market in Saudi Arabia, till 2035
Figure 18.22 Pain Management Devices Market in UAE, till 2035
Figure 18.23 Pain Management Devices Market in Latin America, till 2035
Figure 18.24 Pain Management Devices Market in Brazil, till 2035
Figure 18.25 Pain Management Devices Market in Mexico, till 2035
Figure 18.26 Pain Management Devices Market in Rest of Latin America, till 2035
Figure 18.27 Geographical Regions: Market Movement Analysis
Figure 18.28 Geographical Regions: Penetration-Growth (P-G) Matrix
Figure 20.1 Conclusion: Pain Management Device Developers Market Landscape
Figure 20.2 Conclusion: Publication Analysis
Figure 20.3 Conclusion: Market Forecast and Opportunity Analysis (I/II)
Figure 20.4 Conclusion: Market Forecast and Opportunity Analysis (II/II)

Product Code: RAU1026

The Pain Management Devices Market is valued at USD 7.94 billion in 2024 and is anticipated to grow at a CAGR of 4.8 %, during the forecast period, till 2035.

Pain is a complex phenomenon involving unpleasant sensory experience, primarily associated with acute or chronic physical injury exacerbated by various psychological, biological, and social factors. The prevalence of pain is substantial, affecting a significant number of individuals globally. For instance, in Europe, chronic pain affects approximately 150 million individuals, equivalent to the combined population of France and Germany, leading to an annual economic burden of more than EUR 300 billion. Given the widespread prevalence of pain across various geographies, effective pain management solutions are crucial to improve patient outcomes and enhance the quality of life.

Pain management typically involves the use of pain management devices and therapies to alleviate the suffering of individuals with musculoskeletal pain, spinal and neuropathic pain. Pharmacological interventions, such as opioids, nonsteroidal anti-inflammatory drugs, antidepressants, and antiepileptics, serve as a first-line treatment option for managing and treating both acute and chronic pain. Opioids are considered one of the most widely used pain medications for managing moderate to severe pain, owing to their rapid onset of medicinal effect and ability to provide immediate pain relief. However, these drugs are associated with significant side effects, such as inducing a euphoric state that may hamper daily activities, lower heart rate, and potentially lead to drug addiction and death. It is important to note that in 2019, approximately 600,000 deaths were attributed to drug overdose worldwide, with nearly 80% of these deaths related to the overuse of opioids.

The opioid crisis has prompted industry stakeholders to develop a vast array of patient-centric pain management devices, including neurostimulation devices, infusion pumps, and radiofrequency ablation devices, to manage pain effectively. These devices serve as a second-line treatment option for decreasing pain. These devices offer various advantages, such as minimal or no drug interaction, targeted therapy, reduced dependency on medications, and minimal adverse effects. Moreover, these devices can be tailored to individual needs, enabling adjustments in intensity and treatment duration, thereby improving patient comfort. Given the ongoing research and development efforts of stakeholders to develop patient-centric devices, the global pain management devices market is expected to grow at a healthy CAGR during the forecast period.

Key Market Segments

Type of Device

Neurostimulation Devices
Infusion Pump
Ablation Devices
Virtual Reality Devices
Other Devices

Type of Neurostimulation Device

Spinal Cord Stimulators
Peripheral Nerve Stimulators
Transcutaneous Electrical Nerve Stimulators
Deep Brain Stimulators
Other Stimulators

Application Area

Neuropathic Pain
Musculoskeletal Pain
Cancer Pain
Trauma and Surgical Pain
Facial Pain and Migraine
Other Application Areas

Mode of Purchase

Prescription
Over-the-Counter

End User

Hospitals and Clinics
Physiotherapy Centers
Other End Users

Geographical Regions

North America (US, Canada)
Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
Asia-Pacific (Australia, China, India, Indonesia, Japan, South Korea, Rest of Asia-Pacific)
Middle East and North Africa (Israel, Saudi Arabia, UAE)
Latin America (Brazil, Mexico, Rest of Latin America)

Research Coverage:

A brief introduction to pain and its impact, along with classification of pain and the historical development of the pain management domain over the years. It also provides details on various solutions for pain management, including therapeutics and medical devices. The chapter concludes with discussion on the key future perspectives within the pain management industry.
An overview of the current market landscape of leading pain management device companies, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, type of device (neurostimulation devices, infusion pump, ablation devices, virtual reality devices and other devices), type of neurostimulation device (spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulators, deep brain stimulators and other stimulators), type of ablation device (radiofrequency ablation devices and cryoablation devices), type of analgesic infusion pump (external infusion pump and intrathecal pumps), type of treatment (invasive / minimally invasive and non-invasive), type of pain managed (acute pain and chronic pain), application area (musculoskeletal pain, post-operative pain, neuropathic pain, cancer pain, facial pain and migraine, trauma pain and other application areas).
An insightful competitiveness analysis of the leading players engaged in the pain management devices market, based on several relevant parameters, such as company strength (in terms of years of experience and company size), portfolio strength (based on number of devices offered, type of pain management devices offered and type of pain managed) and application area. It also includes benchmarking analysis of the leading players based on various parameters, such as company strength, number of devices offered, type of pain management devices offered, type of pain managed and application area.
Elaborate profiles of various prominent players that are currently involved in the pain management devices industry. Each company profile features a brief overview of the company, along with information on the location of headquarters, year of establishment, number of employees, business segments, leadership team, contact details, financial information (if available), product portfolio, recent developments and an informed future outlook.
A detailed analysis of over 330 peer-reviewed, scientific articles related to pain management devices, based on several relevant parameters, such as year of publication, type of publication and popular keywords. The chapter also highlights the top journals, top publishers and top copyright holders.
A qualitative Porter's five forces analysis, highlighting the five competitive forces prevalent in the pain management devices market, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute products and rivalry among existing competitors.
An in-depth analysis of the factors that can impact the growth of the pain management devices industry. It also features the identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
A detailed estimate of the current market size, opportunity and the future growth potential for pain management devices, over the next decade. Based on multiple parameters, likely adoption trends and through secondary research, we have provided an informed estimate on the market evolution during the forecast period, till 2035. The report also features the likely distribution of the current and forecasted opportunity. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.
A detailed projection of the current size and future opportunity in the pain management devices market across different types of devices, such as neurostimulation devices, infusion pumps, ablation devices, virtual reality devices and other devices.
A detailed projection of the current size and future opportunity in the pain management devices industry across different types of neurostimulation devices, such as spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulators, deep brain stimulators and other stimulators.
A detailed projection of the current size and future opportunity for pain management device companies across different application areas, such as neuropathic pain, musculoskeletal pain, cancer pain, trauma and surgical pain, facial pain and migraine, and other application areas.
A detailed projection of the current size and future opportunity in the pain management devices market across different modes of purchase, such as prescription mode and over-the-counter mode.
A detailed projection of the current size and future opportunity in the pain management devices industry across different end users, such as hospitals and clinics, physiotherapy centers and other end users.
A detailed projection of the current size and future opportunity in the pain management devices market across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.

Key Benefits of Buying this Report

The report provides valuable insights to market leaders and newcomers regarding the revenue estimations of the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Pain Management Devices Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Companies Profiled

Abbott
AppliedVR
AtriCure
Avanos Medical
Becton, Dickinson and Company
BioElectronics
Hexainnoheal
Litemed
Medtronic
Micrel Medical Devices
Nalu Medical
Nevro
Smileyscope
Stryker
ZetrOZ Systems
Zynex Medical

1. PREFACE

1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
- 2.7.1. Demographics
- 2.7.2. Economic Factors
- 2.7.3. Government Regulations
- 2.7.4. Supply Chain
- 2.7.5. COVID Impact
- 2.7.6. Market Access
- 2.7.7. Healthcare Policies
- 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Future Estimates
- 3.2.2. Currency Coverage and Foreign Exchange Rate
  - 3.2.2.1. Major Currencies Affecting the Market
  - 3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
  - 3.2.2.3. Impact of Foreign Exchange Rate Volatility on The Market
  - 3.2.2.4. Strategies for Mitigating Foreign Exchange Risk
- 3.2.3. Trade Policies
  - 3.2.3.1. Impact of Trade Barriers on the Market
  - 3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Pain and Its Impact
5.3. Classification of Pain
- 5.3.1. Acute Pain
- 5.3.2. Chronic Pain
5.4. Historical Evolution of Pain Management
5.5. Types of Pain Management Solutions
- 5.5.1. Pain Management Therapeutics
- 5.5.2. Pain Management Devices
5.6. Future Perspectives

6. MARKET LANDSCAPE: LEADING PAIN MANAGEMENT DEVICE DEVELOPERS

6.1. Chapter Overview
6.2. Leading Pain Management Device Developers: Overall Market Landscape
- 6.2.1. Analysis by Year of Establishment
- 6.2.2. Analysis by Company Size
- 6.2.3. Analysis by Location of Headquarters
- 6.2.4. Analysis by Company Size and Location of Headquarters
- 6.2.5. Analysis by Type of Pain Management Device
  - 6.2.5.1. Analysis by Type of Neurostimulation Device
  - 6.2.5.2. Analysis by Type of Ablation Device
  - 6.2.5.3. Analysis by Type of Analgesic Infusion Pump
- 6.2.6. Analysis by Type of Treatment
- 6.2.7. Analysis by Type of Pain Managed
- 6.2.8. Analysis by Application Area
- 6.2.9. Analysis by Type of Pain Management Device and Application Area

7. COMPANY COMPETITIVENESS ANALYSIS

7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Leading Pain Management Device Developers: Company Competitiveness Analysis
7.5. Leading Pain Management Device Developers: Benchmarking Analysis
- 7.5.1. Benchmarking of Companies
  - 7.5.1.1. Abbott
  - 7.5.1.2. Medtronic
  - 7.5.1.3. Zynex Medical
  - 7.5.1.4. Boston Scientific
  - 7.5.1.5. OMRON Healthcare
- 7.5.2. Benchmarking of Parameters
  - 7.5.2.1. Leading Pain Management Device Developers: Benchmarking by Competitiveness
  - 7.5.2.2. Leading Pain Management Device Developers: Benchmarking by Portfolio Strength
  - 7.5.2.3. Leading Pain Management Device Developers: Benchmarking by Application Area

8. COMPANY PROFILES

8.1. Chapter Overview
8.2. Abbott
- 8.2.1. Company Overview
- 8.2.2. Financial Information
- 8.2.3. Product Portfolio
- 8.2.4. Recent Developments and Future Outlook
8.3. Avanos Medical
- 8.3.1. Company Overview
- 8.3.2. Financial Information
- 8.3.3. Product Portfolio
- 8.3.4. Recent Developments and Future Outlook
8.4. Becton, Dickinson and Company (BD)
- 8.4.1. Company Overview
- 8.4.2. Financial Information
- 8.4.3. Product Portfolio
- 8.4.4. Recent Developments and Future Outlook
8.5. Medtronic
- 8.5.1. Company Overview
- 8.5.2. Financial Information
- 8.5.3. Product Portfolio
- 8.5.4. Recent Developments and Future Outlook
8.6. Nalu Medical
- 8.6.1. Company Overview
- 8.6.2. Financial Information
- 8.6.3. Product Portfolio
- 8.6.4. Recent Developments and Future Outlook
8.7. Nevro
- 8.7.1. Company Overview
- 8.7.2. Financial Information
- 8.7.3. Product Portfolio
- 8.7.4. Recent Developments and Future Outlook
8.8. ZetrOZ Systems
- 8.8.1. Company Overview
- 8.8.2. Product Portfolio
- 8.8.3. Recent Developments and Future Outlook
8.9. Zynex Medical
- 8.9.1. Company Overview
- 8.9.2. Financial Information
- 8.9.3. Product Portfolio
- 8.9.4. Recent Developments and Future Outlook
8.10. Key Winning Strategies of Leading Players
8.11. Other Leading Players
- 8.11.1. AppliedVR
- 8.11.2. AtriCure
- 8.11.3. BioElectronics

8.11.4.Hexainnoheal

8.11.5. Litemed
8.11.6. Micrel Medical Devices
8.11.7. Smileyscope
8.11.8. Stryker

8.12. Key Winning Strategies of Other Leading Players

9. PUBLICATION ANALYSIS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Pain Management Devices: Publication Analysis
- 9.3.1. Analysis by Year of Publication
- 9.3.2. Analysis by Type of Publication
- 9.3.3. Analysis by Copyright Holders
- 9.3.4. Word Cloud: Emerging Focus Areas
- 9.3.5. Most Active Publishers: Analysis by Number of Publications
- 9.3.6. Key Journals: Analysis by Number of Publications
- 9.3.7. Key Journals: Analysis by Impact Factor

10. PORTER'S FIVE FORCES ANALYSIS

10.1. Chapter Overview
10.2. Methodology and Assumptions
10.3. Key Parameters
- 10.3.1. Threats of New Entrants
- 10.3.2. Bargaining Power of End-Users
- 10.3.3. Bargaining Power of Product Developers
- 10.3.4. Threats of Substitute Products
- 10.3.5. Rivalry Among Existing Competitors
10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS

11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL PAIN MANAGEMENT DEVICES MARKET

12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Pain Management Devices Market, till 2035
- 12.3.1. Scenario Analysis
12.4. Key Market Segmentations

13. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF PAIN MANAGEMENT DEVICE

13.1. Chapter Overview
13.2. Assumptions and Methodology
13.3. Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
- 13.3.1. Pain Management Devices Market for Neurostimulation Devices, till 2035
- 13.3.2. Pain Management Devices Market for Infusion Pumps, till 2035
- 13.3.3. Pain Management Devices Market for Ablation Devices, till 2035
- 13.3.4. Pain Management Devices Market for Virtual Reality Devices, till 2035
- 13.3.5. Pain Management Devices Market for Other Pain Management Devices, till 2035
13.4. Data Triangulation and Validation

14. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF NEUROSTIMULATION DEVICE

14.1. Chapter Overview
14.2. Assumptions and Methodology
14.3. Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
- 14.3.1. Pain Management Devices Market for Spinal Cord Stimulators, till 2035
- 14.3.2. Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035
- 14.3.3. Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035
- 14.3.4. Pain Management Devices Market for Deep Brain Stimulators, till 2035
- 14.3.5. Pain Management Devices Market for Other Stimulators, till 2035
14.4. Data Triangulation and Validation

15. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION AREA

15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
- 15.3.1. Pain Management Devices Market for Neuropathic Pain, till 2035
- 15.3.2. Pain Management Devices Market for Musculoskeletal Pain, till 2035
- 15.3.3. Pain Management Devices Market for Cancer Pain, till 2035
- 15.3.4. Pain Management Devices Market for Trauma and Surgical Pain, till 2035
- 15.3.5. Pain Management Devices Market for Facial Pain and Migraine, till 2035
- 15.3.6. Pain Management Devices Market for Other Application Areas, till 2035
15.4. Data Triangulation and Validation

16. PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

16.1. Chapter Overview
16.2. Assumptions and Methodology
16.3. Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
- 16.3.1. Pain Management Devices Market for Prescription, till 2035
- 16.3.2. Pain Management Devices Market for Over-the-Counter, till 2035
16.4. Data Triangulation and Validation

17. PAIN MANAGEMENT DEVICES MARKET, BY END USERS

17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. Pain Management Devices Market: Distribution by End Users, 2024 and 2035
- 17.3.1. Pain Management Devices Market for Hospitals and Clinics, till 2035
- 17.3.2. Pain Management Devices Market for Physiotherapy Centers, till 2035
- 17.3.3. Pain Management Devices Market for Other End Users, till 2035
17.4. Data Triangulation and Validation

18. PAIN MANAGEMENT DEVICES MARKET, BY GEOGRAPHICAL REGIONS

18.1. Chapter Overview
18.2. Assumptions and Methodology
18.3. Pain Management Devices Market: Distribution by Geographical Regions, 2024 and 2035
- 18.3.1. Pain Management Devices Market in North America, till 2035
  - 18.3.1.1. Pain Management Devices Market in the US, till 2035
  - 18.3.1.2. Pain Management Devices Market in Canada, till 2035
- 18.3.2. Pain Management Devices Market in Europe, till 2035
  - 18.3.2.1. Pain Management Devices Market in Germany, till 2035
  - 18.3.2.2. Pain Management Devices Market in France, till 2035
  - 18.3.2.3. Pain Management Devices Market in the UK, till 2035
  - 18.3.2.4. Pain Management Devices Market in Spain, till 2035
  - 18.3.2.5. Pain Management Devices Market in Italy, till 2035
  - 18.3.2.6. Pain Management Devices Market in Rest of Europe, till 2035
- 18.3.3. Pain Management Devices Market in Asia-Pacific, till 2035
  - 18.3.3.1. Pain Management Devices Market in China, till 2035
  - 18.3.3.2. Pain Management Devices Market in Japan, till 2035
  - 18.3.3.3. Pain Management Devices Market in Australia, till 2035
  - 18.3.3.4. Pain Management Devices Market in India, till 2035
  - 18.3.3.5. Pain Management Devices Market in South Korea, till 2035
  - 18.3.3.6. Pain Management Devices Market in Rest of Asia-Pacific, till 2035
- 18.3.4. Pain Management Devices Market in Middle East and North Africa, till 2035
  - 18.3.4.1. Pain Management Devices Market in Israel, till 2035
  - 18.3.4.2. Pain Management Devices Market in Saudi Arabia, till 2035
  - 18.3.4.3. Pain Management Devices Market in UAE, till 2035
- 18.3.5. Pain Management Devices Market in Latin America, till 2035
  - 18.3.5.1. Pain Management Devices Market in Brazil, till 2035
  - 18.3.5.2. Pain Management Devices Market in Mexico, till 2035
  - 18.3.5.3. Pain Management Devices Market in Rest of Latin America, till 2035
18.4. Geographical Regions: Market Movement Analysis
18.5. Geographical Regions: Penetration-Growth (P-G) Matrix
18.6. Data Triangulation and Validation

疼痛管理デバイス市場：2035年までの業界動向と世界の予測 - デバイスタイプ別、神経刺激デバイスタイプ別、応用分野別、購入形態別、エンドユーザー別、地域別

Pain Management Devices Market, Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Device, Type of Neurostimulation Device, Application Area, Mode of Purchase, End User and Geographical Regions

目次

第1章 序文

第2章 調査手法

第3章 経済およびその他のプロジェクト特有の考慮事項

第4章 エグゼクティブサマリー

第5章 イントロダクション

第6章 市場情勢：主要な疼痛管理デバイス開発企業

第7章 企業競争力分析

第8章 企業プロファイル

第9章 出版物の分析

第10章 ポーターのファイブフォース分析

第11章 市場影響分析

第12章 世界の疼痛管理デバイス市場

第13章 疼痛管理デバイス市場、疼痛管理デバイスタイプ別

第14章 疼痛管理デバイス市場、神経刺激デバイスタイプ別

第15章 疼痛管理デバイス市場、応用分野別

第16章 疼痛管理デバイス市場、購入形態別

第17章 疼痛管理デバイス市場、エンドユーザー別

第18章 疼痛管理デバイス市場、地域別

第19章 疼痛管理デバイス市場、主要業界参入企業別分析

第20章 結論

第21章 付録1：表形式のデータ

第22章 付録2企業および組織の一覧

List of Tables

List of Figures

TABLE OF CONTENTS

1. PREFACE

2. RESEARCH METHODOLOGY

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. MARKET LANDSCAPE: LEADING PAIN MANAGEMENT DEVICE DEVELOPERS

7. COMPANY COMPETITIVENESS ANALYSIS

8. COMPANY PROFILES

9. PUBLICATION ANALYSIS

10. PORTER'S FIVE FORCES ANALYSIS

11. MARKET IMPACT ANALYSIS

12. GLOBAL PAIN MANAGEMENT DEVICES MARKET

13. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF PAIN MANAGEMENT DEVICE

14. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF NEUROSTIMULATION DEVICE

15. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION AREA

16. PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

17. PAIN MANAGEMENT DEVICES MARKET, BY END USERS

18. PAIN MANAGEMENT DEVICES MARKET, BY GEOGRAPHICAL REGIONS

19. PAIN MANAGEMENT DEVICES MARKET, BY LEADING INDUSTRY PLAYERS

20. CONCLUSION

21. APPENDIX 1: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION

第1章序文

第2章調査手法

第3章経済およびその他のプロジェクト特有の考慮事項

第4章エグゼクティブサマリー

第5章イントロダクション

第6章市場情勢：主要な疼痛管理デバイス開発企業

第7章企業競争力分析

第8章企業プロファイル

第9章出版物の分析

第10章ポーターのファイブフォース分析

第11章市場影響分析

第12章世界の疼痛管理デバイス市場

第13章疼痛管理デバイス市場、疼痛管理デバイスタイプ別

第14章疼痛管理デバイス市場、神経刺激デバイスタイプ別

第15章疼痛管理デバイス市場、応用分野別

第16章疼痛管理デバイス市場、購入形態別

第17章疼痛管理デバイス市場、エンドユーザー別

第18章疼痛管理デバイス市場、地域別

第19章疼痛管理デバイス市場、主要業界参入企業別分析

第20章結論

第21章付録1：表形式のデータ

第22章付録2企業および組織の一覧